Trending News

Supreme Court Eliminates Heightened Discrimination Standard Under Title VII

Cleaning the Cupboard—Six More Decisions in One Day, and a Largely Harmonious Court - SCOTUS Today

U.S. Supreme Court Holds Majority-Group Plaintiffs Are Not Subject to a Heightened Evidentiary Standard Under Title VII

Supreme Court Clarifies Title VII Evidentiary Standards in “Reverse Discrimination” Cases, Removing Heightened Standard

“Supreme Court Shakes Things Up: Reversal of the ‘Background Circumstances’ Rule Marks Major Legal Shift”

SCOTUS Levels the Field for “Reverse” Discrimination: Potential Consequences

Supreme Court Invalidates "Background Circumstances" Rule in Title VII Cases

SCOTUS Unanimously Holds One Standard for Discrimination Cases Under Title VII

Changes to Civil Rights Enforcement: New Executive Order Eliminates Disparate-Impact Liability in Federal Regulations

How Are Family Offices Building Smarter Wealth? Structural Alpha (11 Examples)

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

I-Mab Regains Compliance with Nasdaq Minimum Bid Price Requirement
Posted On Thursday, June 12, 2025
Levicept to Present Further Analysis from Phase II Trial of Novel Neurotrophin-3 Inhibitor, LEVI-04, at EULAR
Posted On Thursday, June 12, 2025
Editas Medicine Reports Proprietary Targeted Lipid Nanoparticle Delivery in Non-Human Primates Enables In Vivo HBG1/2 Promoter Editing for Sickle Cell Disease and Beta Thalassemia at the European Hematology Association 2025 Congress in June
Posted On Thursday, June 12, 2025
Dapirolizumab Pegol Phase 3 Data in SLE Presented at the Annual European Congress of Rheumatology (EULAR) Show Improvement in Fatigue and Reduction in Disease Activity
Posted On Thursday, June 12, 2025
Nusano Announces Breakthrough HALEU Program Expected to Produce Up to 350 Metric Tons of Fuel Annually for Advanced Nuclear Reactors
Posted On Wednesday, June 11, 2025
MediPharm Reminds Shareholders to Vote in Advance of June 13 Deadline
Posted On Wednesday, June 11, 2025
MediPharm Announces Complete Dismissal of Dissident Court Proceeding Related to Annual and Special Meeting
Posted On Wednesday, June 11, 2025
Accomplished Biotech Executive Frederick Beddingfield III, M.D., Ph.D. Joins Neurodon’s Board of Directors
Posted On Wednesday, June 11, 2025
Result of General Meeting
Posted On Wednesday, June 11, 2025
AIM ImmunoTech Announces 1-for-100 Reverse Stock Split
Posted On Wednesday, June 11, 2025
Fortrea Names Anshul Thakral Chief Executive Officer
Posted On Wednesday, June 11, 2025
Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors
Posted On Wednesday, June 11, 2025
BIOFRONTERA INC. IS NEGOTIATING FUNDAMENTAL CHANGES TO ITS COOPERATION WITH BIOFRONTERA AG
Posted On Wednesday, June 11, 2025
Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders
Posted On Wednesday, June 11, 2025
Cabaletta Bio Announces Pricing of Public Offering of Securities
Posted On Wednesday, June 11, 2025
Capricor Therapeutics Announces Key Regulatory Updates for its Duchenne Muscular Dystrophy Program
Posted On Wednesday, June 11, 2025
Moleculin Participates in Virtual Investor “What This Means” Segment
Posted On Wednesday, June 11, 2025
Fate Therapeutics Announces Updated Clinical Data for FT819 Off-the-shelf CAR T-cell Product Candidate Demonstrating Durability of Drug-free Remission for Severe Lupus Nephritis at EULAR 2025 Congress
Posted On Wednesday, June 11, 2025
Precision Neuroscience Expands Leadership Team With Key Hires From Meta and FDA
Posted On Wednesday, June 11, 2025
Windtree Receives Offer for Its Preclinical Oncology Drug Candidate
Posted On Wednesday, June 11, 2025
OKYO Pharma to Present at the Bio International Convention
Posted On Wednesday, June 11, 2025
Lisata Therapeutics to Present at the 2025 BIO International Convention
Posted On Wednesday, June 11, 2025
Artelo Biosciences Announces Reverse Stock Split
Posted On Wednesday, June 11, 2025
Global Billion Dollar Oncology Industry Experiencing Substantial Growth Driven by Increasing Cancer Incidences
Posted On Wednesday, June 11, 2025
Veru to Participate in the Virtual BTIG Obesity Health Forum
Posted On Wednesday, June 11, 2025

Print